Sino-Agri Leading Biosciences Co., Ltd. Class A

Sino-Agri Leading Biosciences Co., Ltd. Class A

SSSE:603970
9.78
CNY
-0.08
(-0.81%)
0.55EPS
21.15P/E
3.18BMarket Cap
Apr 20Next Earn

Total Valuation

CNY

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A carries a market capitalization of 3.18B, placing it among publicly traded companies globally. Its enterprise value stands at 2.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.18B
Enterprise Value2.97B

Important Dates

Sino-Agri Leading Biosciences Co., Ltd. Class A's next confirmed earnings release is scheduled for April 20, 2027.

Earnings Date4/20/2027

Share Statistics

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A has 268.80M shares outstanding.

Shares Outstanding268.80M

Valuation Ratios

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 21.15. The price-to-sales ratio is 0.28, and the price-to-book ratio stands at 1.99.

PE Ratio21.15
PS Ratio0.28
PB Ratio1.99
P/TBV Ratio1.99

Enterprise Valuation

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A trades at an EV/EBITDA multiple of 14.82 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.27 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 14.82 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.97B versus a market cap of 3.18B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.27
EV / EBITDA14.82
EV / EBIT14.82

Financial Position

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.11, indicating elevated leverage, while an interest coverage ratio of 11.13 demonstrates strong ability to service its debt obligations.

Current Ratio1.37
Quick Ratio0.17
Debt / Equity19.11
Debt / EBITDA1.68
Interest Coverage11.13

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A posted a return on equity (ROE) of 9.58, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.21 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.38, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.97, useful for judging operating efficiency across full business cycles. The company generates approximately 15.18M in revenue per employee across its workforce of 736.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.74 indicates how many times Sino-Agri Leading Biosciences Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)9.58
Return on Assets (ROA)2.38
Return on Invested Capital (ROIC)6.21
Return on Capital Employed (ROCE)6.97
Revenue Per Employee15.18M
Employee Count736.00
Inventory Turnover5.74

Taxes

CNY

Over the twelve months ended September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A recorded 45.48M in income tax expense. That works out to an effective tax rate of 23.60, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 192.71M, leaving 150.48M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax45.48M
Effective Tax Rate23.60

Stock Price Statistics

CNY

As of the close on November 17, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A's stock has declined approximately 29.89% over the past 52 weeks. The 50-day moving average sits at 10.81, while the 200-day moving average is 11.66.

52-Week Price Change-29.89%
50-Day Moving Average10.81
200-Day Moving Average11.66

Income Statement

CNY

Over the twelve months ended September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A generated 11.17B in revenue and converted that into 150.48M in net income, yielding earnings per share of 0.55. EBITDA reached 200.01M, while operating income came in at 309.71M.

Revenue11.17B
Gross Profit662.13M
Operating Income309.71M
Pretax Income192.71M
Net Income150.48M
EBITDA200.01M
EBIT200.01M
Earnings Per Share (EPS)0.55

Balance Sheet

CNY

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A holds 703.88M in cash and equivalents against 335.11M in total debt, resulting in a net debt position of 71.52M. Total book value stands at 1.60B, with working capital of 1.53B providing operational flexibility.

Cash & Cash Equivalents703.88M
Total Debt335.11M
Net Debt71.52M
Equity (Book Value)1.60B
Book Value Per Share5.96
Working Capital1.53B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-3.71M

Margins

Over the twelve months ended September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A posted a gross margin of 5.93, reflecting its pricing power and cost economics. The operating margin of 2.77 and net profit margin of 1.35 provide insight into operational efficiency.

Gross Margin5.93
Operating Margin2.77
Pretax Margin1.73
Profit Margin1.35
EBITDA Margin1.79

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A paid dividends of 0.38 per share. The dividend payout ratio of 70.96 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 36.54, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sino-Agri Leading Biosciences Co., Ltd. Class A shareholders.

Dividend Per Share0.38
Payout Ratio70.96
Shareholder Yield36.54

Stock Splits

Sino-Agri Leading Biosciences Co., Ltd. Class A's most recent stock split took place on June 13, 2023 with a 5:7 split ratio.

Last Split Date6/13/2023
Split Ratio5:7

Scores

As of September 30, 2026, Sino-Agri Leading Biosciences Co., Ltd. Class A has an Altman Z-Score of 3.07, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.07